Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Accumulated Expenses: 2021-2022

Historic Accumulated Expenses for Milestone Pharmaceuticals (MIST) over the last 2 years, with Sep 2022 value amounting to $1.9 million.

  • Milestone Pharmaceuticals' Accumulated Expenses rose 82.19% to $1.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.9 million, marking a year-over-year increase of 82.19%. This contributed to the annual value of $1.5 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Milestone Pharmaceuticals reported Accumulated Expenses of $1.9 million as of Q3 2022, which was up 251.23% from $527,000 recorded in Q2 2022.
  • Over the past 5 years, Milestone Pharmaceuticals' Accumulated Expenses peaked at $1.9 million during Q3 2022, and registered a low of $516,000 during Q1 2021.
  • Moreover, its 2-year median value for Accumulated Expenses was $740,000 (2021), whereas its average is $948,000.
  • Examining YoY changes over the last 5 years, Milestone Pharmaceuticals' Accumulated Expenses showed a top increase of 82.19% in 2022 and a maximum decrease of 28.78% in 2022.
  • Milestone Pharmaceuticals' Accumulated Expenses (Quarterly) stood at $1.5 million in 2021, then soared by 82.19% to $1.9 million in 2022.
  • Its last three reported values are $1.9 million in Q3 2022, $527,000 for Q2 2022, and $528,000 during Q1 2022.